FMR CORP 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 612,427 6.062% |
-164,860 (-21.21%) |
Filing |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 777,287 7.793% |
-310,098 (-28.52%) |
Filing |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
FMR CORP | 1,087,385 11.011% |
930,157 (+591.60%) |
Filing |